Reconciled ClinicalTrials.gov v2 Protocol Specification
| Protocol Field | Verified Registry Value |
|---|---|
| NCT Identifier | NCT07449754 |
| Consolidated Lead Sponsor | Hanmi Pharmaceutical Company Limited |
| Therapeutic Condition Cohort | Oncology and Hematology |
| Clinical Trial Phase | Phase II |
| Overall Recruitment Status | RECRUITING |
| Registered Enrollment | 45 participants (ESTIMATED) |
| Registered Start Date | 2026-02-12 |
| WhyStopped Classification | Not Stopped |
Named U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Site Profile |
|---|---|---|
| Seoul National University Bundang Hospital | Seongnam-si, South Korea | Open Hospital Dossier -> |
| Chonnam National University Hwasun Hospital | Hwasun, South Korea | Open Hospital Dossier -> |
| Kyungpook National University Chilgok Hospital | Daegu, South Korea | Open Hospital Dossier -> |
| Chungnam National University Hospital | Daejeon, South Korea | Open Hospital Dossier -> |
Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.